RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations
暂无分享,去创建一个
F. Buchholz | M. Seifert | I. Roeder | Maciej Paszkowski-Rogacz | C. Thiede | M. Bornhäuser | Shady Sayed | Aylin Camgöz | O. Sidorova | Michael Seifert